TP53 and cholangiocarcinoma: We analyzed miRNA profiles using sequences of small RNAs from two genetically altered CCA cell lines (p53-mutant KKU-213B and p53-wildtype KKK-D068H1) to reduce the heterogeneity of CCA and incorporate a control of MMNK1 immortalized cholangiocyte cell line.